RE: Placing22 May 2025 08:21
You seem to be right about the pattern.
This is from the March 1st 2024 fundraiser RNS:
"Commenting, Dr Dan Gooding, Executive Director of Nuformix, said: "The funds raised through the Subscription will support the Company as we focus on discussions with potential licensees and the overall progression of the NXP002 programme to improve the treatment of IPF via inhalation.Β I look forward to providing further updates in due course."
Sound familiar?